We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Chim Lang MD

Chim C. Lang MD

Professor of Cardiology; Head, Division of Molecular and Clinical Medicine, University of Dundee, Scotland, United Kingdom

Dr. Ling is Professor of Cardiology and Head of the Division of Molecular and Clinical Medicine at the University of Dundee, Scotland, United Kingdom.

Disclosures

Dr. Lang reports a grant from Novo Nordisk to serve as National Coordinator and site principal investigator for the SELECT trial, which is sponsored by Novo Nordisk; receiving grants to serve as site principal investigator for clinical trials funded by Applied Therapeutics, Anacardio AB, Astra Zeneca, Boehringher Ingelheim, and Moderna Inc, outside the submitted work. He also served as a compensated consultant on advisory committees for Astra Zeneca, Boehringer Ingelheim, Novartis and Novo Nordisk.